Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies

Immunology

Volumn 130, Issue 3, 2010, Pages 427-435

  Hagedorn, Peter H ^a   Burton, Christopher M ^b   Carlsen, Jørn ^b   Steinbrüchel, Daniel ^b   Andersen, Claus B ^b   Sahar, Eli ^c   Domany, Eytan ^d   Cohen, Irun R ^d   Flyvbjerg, Henrik ^a   Iversen, Martin ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c ImmunArray Ltd   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Antigen microarray; Apoptosis; Autoantibodies; Bronchiolitis obliterans syndrome; Lung transplantation

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ANTIGEN MICROARRAY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; HUMAN; LUNG TRANSPLANTATION; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM; UPREGULATION;

ADULT; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; BLOOD PRESSURE; BRONCHIOLITIS OBLITERANS; CHEMOTAXIS; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUNG TRANSPLANTATION; MALE; METABOLIC NETWORKS AND PATHWAYS; MICROARRAY ANALYSIS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROTEINS;

EID: 77953492944     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03246.x     Document Type: Article

References (42)

1. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
2. Reichenspurner H, Girgis RE, Robbins RC et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996 62 : 1467 1472.
3. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007 26 : 681 686.
4. Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 : 782 795.
5. Walters EH, Reid DW, Johns DP, Ward C. Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling. Eur Respir J 2007 30 : 574 588.
6. Belperio JA, Weight SS, Fishbein MC, Lynch JP. Chronic lung allograft rejection. Mechanisms and therapy. Proc Am Thorac Soc 2009 6 : 108 121.
7. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002 21 : 271 281.
8. Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. J Heart Lung Transplant 2009 28 : 888 893.
9. El-Gamel A, Sim E, Hasleton P et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999 18 : 828 837.
10. Jaramillo A, Fernández FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005 9 : 84 93. (Pubitemid 40238970)
11. Rose ML. Role of MHC and non-MHC alloantibodies in graft rejection. Curr Opin Organ Transplant 2004 9 : 16 22.
12. Shilling RA, Wilkes DS. Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond. Am J Transplant 2009 9 : 1714 1718.
13. Yoshida S, Haque A, Mizobuchi T et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well healed lung transplants. Am J Transplant 2006 6 : 724 735.
14. Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 2004 286 : L1129 39.
15. Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T. De novo production of K-alpha 1 tubulin-specific antibodies: role in chronic allograft rejection. J Immunol 2008 180 : 4487 4494.
16. Fukami N, Ramachandran S, Saini D et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009 182 : 309 318.
17. Quintana FJ, Hagedorn PH, Elizur G, Merbl Y, Domany E, Cohen IR. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A 2004 101 (Suppl. 2 14615 14621.
18. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A 2007 104 : 17494 17499.
19. Merbl Y, Itzchak R, Vider-Shalit T, Louzoun Y, Quintana FJ, Vadai E, Eisenbach L, Cohen IR. A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice. PLoS ONE 2009 4 : e6053.
20. Quintana FJ, Faraz MF, Viglietta V et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A 2008 105 : 18889 18894.
21. Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, Iversen M. Survival after single lung, double lung, and heart lung transplantation. J Heart Lung Transplant 2005 24 : 1834 1843.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995 57 : 289 300.
23. Lage K, Karlberg E, Størling Z et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007 25 : 309 316.
24. Butland G, Peregrín-Alvarez JM, Li J et al. Interaction network containing conserved and essential protein complexes in Escherichia coli. Nature 2005 433 : 531 537.
25. Lage K, Hansen NT, Karlberg E et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A 2008 105 : 20870 20875.
26. de Lichtenberg U, Jensen LJ, Brunak S, Bork P. Dynamic complex formation during the yeast cell cycle. Science 2005 307 : 724 727.
27. Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules. J Clin Invest 2007 117 : 712 718.
28. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005 4 : 139 163.
29. Hansen PR, Holm AM, Svendsen UG, Olsen PS, Andersen CB. Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis. J Heart Lung Transplant 2000 19 : 160 166.
30. Neuringer IP, Aris RM, Burns KA, Bartolotta TL, Chalermskulrat W. Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant 2002 2 : 410 419.
31. Maruyama T, Jaramillo A, Narayanan K, Higuchi T, Mohanakumar T. Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant 2005 9 : 2126 2134.
32. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004 5 : 897 907.
33. Chandra D, Choy G, Tang DG. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J Biol Chem 2007 282 : 31289 31301.
34. Caldas CE, Luna E, Spadafora-Ferreira M et al. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft infiltrating responses. Clin Exp Immunol 2006 146 : 66 75.
35. Cohen IR, Cooke A. Natural autoantibodies might prevent autoimmune disease. Immunol Today 1986 7 : 363 364.
36. Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today 1992 13 : 490 494.
37. Cohen IR. Tending Adam's Garden: Evolving the Cognitive Immune Self.
38. Dragun D, Müller DN, Bräsen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005 352 : 558 569.
39. Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol 2006 6 : 271 276.
40. Platten M, Youssef S, Hur EM et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009 106 : 14948 14953.
41. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 2005 307 : 430 433.
42. Mamessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M. T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 2007 84 : 908 916.